Expanding the Horizons of Phototherapy: A Review on the Superior Performance of Chalcogen‐Based Photosensitizers and Photothermal Agents for Cancer Therapy
Subhrakant Jena,
No information about this author
Pranay Mohanty,
No information about this author
L. K. Dash
No information about this author
et al.
ChemPhotoChem,
Journal Year:
2025,
Volume and Issue:
unknown
Published: April 10, 2025
Phototherapy,
encompassing
photodynamic
therapy
(PDT)
and
photothermal
(PTT),
presents
a
promising
cancer
treatment
strategy
with
high
spatial
specificity
minimal
invasiveness.
Optimizing
these
techniques
hinges
on
the
design
of
high‐performance
photosensitizers
(PSs)
agents
(PTAs).
Single‐atom
chalcogen
substitution,
at
both
endocyclic
exocyclic
positions
in
conventional
organic
chromophores,
has
proven
to
be
novel
for
enhancing
their
photophysical
photochemical
properties.
Ideal
PSs/PTAs
exhibit
biocompatibility,
visible‐to‐near‐infrared
(vis–NIR)
absorption,
efficient
triplet
state
harvesting,
feasible
heat
energy
transfer
efficiency.
Moreover,
chalcogen‐based
show
promise
synergistic
multimodal
therapies,
integrating
imaging
treatment.
This
review
comprehensively
examines
recent
advancements
(within
last
five
years)
utilizing
substitution
robust
PDT/PTT.
It
provides
holistic
perspective
spectroscopic
characterization
computational
analyses,
singlet‐oxygen/triplet
quantum
yields,
generation
efficiency,
vitro/in
vivo
biological
evaluations
chalcogen‐substituted
PSs/PTAs.
is
anticipated
that
this
will
stimulate
further
research
endeavors
area.
Language: Английский
Nanozymes in cancer immunotherapy: metabolic disruption and therapeutic synergy
X Xu,
No information about this author
Yaowen Zhang,
No information about this author
Chijun Meng
No information about this author
et al.
Journal of Materials Chemistry B,
Journal Year:
2024,
Volume and Issue:
12(37), P. 9111 - 9143
Published: Jan. 1, 2024
The
unique
roles
of
nanozymes
in
enhancing
immunotherapy
through
disrupting
tumor
metabolism
and
mediating
combination
therapies.
Language: Английский
Transition Metal Complex‐Loaded Nanosystems: Advances in Stimuli‐Responsive Cancer Therapies
Small,
Journal Year:
2024,
Volume and Issue:
unknown
Published: Dec. 11, 2024
Transition
metal
complex-loaded
nanosystems
(TMCNs)
represent
a
cutting-edge
platform
for
stimuli
(light,
ultrasound)-responsive
cancer
therapies.
These
nanosystems,
incorporating
metals
such
as
manganese(II),
zinc(II),
ruthenium(II),
rhenium(I),
iridium(III),
and
platinum(IV),
significantly
enhance
the
efficacy
of
light-activated
therapies,
including
photodynamic
therapy
(PDT)
photothermal
(PTT),
well
ultrasound-activated
treatments
like
sonodynamic
(SDT).
TMCNs
based
on
iridium(III)
improve
PDT,
while
manganese(II)
demonstrate
exceptional
sonosensitizing
properties.
In
PTT,
ruthenium(II)
iridium(III)-based
efficiently
absorb
light
generate
heat.
Emerging
synergistic
approaches
that
combine
SDT,
chemotherapy,
immunotherapy
are
demonstrated
to
be
powerful
strategies
precision
treatment.
Zinc(II),
platinum(IV)-based
play
critical
role
in
optimizing
these
enhancing
tumor
targeting,
reducing
side
effects.
Furthermore,
can
amplify
by
inducing
immunogenic
cell
death,
thus
strengthening
immune
response.
advances
address
key
challenges
hypoxia
therapeutic
resistance,
opening
new
possibilities
innovative
photosensitizer-based
treatments.
This
review
highlights
latest
progress
design
applications,
demonstrating
their
potential
revolutionize
stimuli-responsive
Language: Английский
Photovoltaic Molecule‐Based Phototheranostics With A‐D‐A Structure for Near‐Infrared Fluorescence Imaging‐Guided Synergetic Photodynamic and Photothermal Therapy of Tumors
Liang Chen,
No information about this author
Jierou Huang,
No information about this author
Ming Tong
No information about this author
et al.
Luminescence,
Journal Year:
2024,
Volume and Issue:
39(10)
Published: Oct. 1, 2024
ABSTRACT
Phototheranostics
with
near‐infrared
fluorescence
and
reactive
oxygen
species
generation
ability
high
photothermal
conversion
efficiency
(PCE)
plays
a
significant
role
in
imaging‐guided
synergetic
photodynamic
therapy
of
tumors.
Here,
star
molecule
organic
photovoltaic
materials,
NCBDT‐4C
an
A‐D‐A
conjugated
structure,
was
assembled
DSPE‐PEG‐NH
2
to
prepare
water
dispersive
nanoparticles
(NPs).
The
prepared
NCBDT‐4Cl
NPs
exhibited
maximum
NIR
absorption
peak
at
764
nm
798
nm.
These
could
generate
superoxide
anion,
singlet
(
1
O
),
heat
under
808
laser
irradiation.
quantum
yield
PCE
the
were
37.5%
53.6%,
respectively.
combination
cancer
demonstrated
vitro
vivo.
This
work
presents
advanced
application
materials
phototherapy.
Language: Английский
One-Pot Synthesis of Tumor-Targeted Gold-Doped Cu1.92S Plasmonic Nanodots for Enhanced NIR-Triggered, pH-Responsive PTT/PDT/CDT
ACS Applied Materials & Interfaces,
Journal Year:
2024,
Volume and Issue:
17(1), P. 408 - 418
Published: Dec. 25, 2024
Copper-based
sulfides
are
attractive
candidates
for
NIR
I
and
II
responsive
photothermal
therapy
but
often
suffer
from
high
hydrophobicity,
suboptimal
conversion,
poor
biostability
biocompatibility.
In
the
present
work,
a
rapid,
one-pot
synthesis
method
was
developed
to
obtain
Au-doped
Cu1.92S
(ACSH
NDs)
dual
plasmonic
nanodots.
ACSH
NDs
exhibit
excellent
peroxidase-like
catalytic
activity
pH-responsive
•OH
radical
generation
along
with
efficient
glutathione
depletion
under
tumor
microenvironment
mimicking
conditions.
Upon
exposure
NIR-I
laser
light,
demonstrate
conversion
efficiency
of
47.44%
as
well
significant
photodynamic
effect
through
singlet
oxygen
generation.
The
in
situ
hyaluronic
acid
capping
endows
nanodots
highly
selective
uptake
breast
cancer
cells
both
vitro
vivo.
Simultaneous
chemodynamic
NIR-triggered
photothermal/photodynamic
activities
result
synergistic
cell
death
98%
inhibition
single-dose
mouse
model
study.
Therefore,
show
remarkable
potential
single
nanoplatform-actuated
drug-free
multimodal
therapy.
Language: Английский